SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent Pharma Solutions, Inc. announced today the appointment of Barry Littlejohns as President, Medication Delivery Solutions, effective July 5, 2011. Mr. Littlejohns will have full responsibility for Catalent’s Sterile Technologies and Packaging Services segments, including leading more than 2,300 employees at six facilities in both North America and Europe. Mr. Littlejohns will report to John Chiminski, President and CEO of Catalent, and will be based in Catalent’s Somerset, New Jersey global headquarters. Barry Russell, the current incumbent, will simultaneously step down from the role.
Mr. Littlejohns rejoins Catalent after two years at Danish biotechnology company Genmab, where he most recently served as Senior Vice President of Operations and Business Development. Prior to Genmab, Mr. Littlejohns served in a broad variety of leadership roles within Catalent during his twenty year tenure, most recently Vice President of Global Business Operations, Vice President and General Manager of Injectables. Before that, Mr. Littlejohns served in a variety of financial, operational and leadership roles in Catalent’s drug delivery business.
John Chiminski, Catalent’s President and CEO, said, “We are very pleased to welcome Barry back to Catalent in this important role.” Mr. Chiminski continued, “Barry is a proven growth leader, with proven abilities to effectively lead teams and transform operational performance. I expect Barry will help us consolidate and extend our operational improvements in the sterile and packaging areas, and to ensure these businesses reach their full growth potential.”
From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. Catalent employs approximately 8,000 people at 24 facilities worldwide and in fiscal year 2010 generated more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, NJ. For more information, visit www.catalent.com.
more products. better treatments. reliably supplied.™
Catalent Pharma Solutions, Inc.
Patricia McGee, 732-537-6407
KEYWORDS: United States North America New Jersey
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical Manufacturing Packaging Other Manufacturing